Impactive Capital’s Meridian Bioscience VIVO Stock Holding History
Bought
Maintained
Sold
Other funds holding VIVO
Impactive Capital's VIVO Position: Q4 2022 in Review
Impactive Capital sold out of Meridian Bioscience (VIVO) in Q4 2022, closing a stake of 2,884,490 shares — an estimated $90.9M sold.
Impactive Capital first reported a position in VIVO in Q4 2021 and held it in 4 quarters. The position peaked at $131M in Q2 2022. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.
- Impactive Capital reported no remaining Meridian Bioscience position as of Q4 2022 after selling out during the quarter.
- Impactive Capital sold 2,884,490 Meridian Bioscience shares in Q4 2022, an estimated $90.9M.
- Impactive Capital first reported a position in Meridian Bioscience in Q4 2021 and held it in 4 quarters.
- Impactive Capital's Meridian Bioscience position peaked at $131M in Q2 2022.
- 218 funds tracked by Wall St. Rank held Meridian Bioscience as of Q4 2022.
Based on Impactive Capital's 13F filing for Q4 2022, filed 14 Feb 2023.